Blacktown Hospital is an acute care hospital in Blacktown, New South Wales, Australia, about 34 kilometres from the Sydney CBD. Together with Mount Druitt Hospital and associated community health centres, it is a part of the Western Sydney Local Health District.

During the past decade, Blacktown Hospital conducted 66 clinical trials. In the 10-year time frame, 66 clinical trials started and 3 clinical trials were completed, i.e. on average, 4.5% percent of trials that started reached the finish line to date. In the past 5 years, 46 clinical trials started and 3 clinical trials were completed. i.e. 6.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Blacktown Hospital" #1 sponsor was "Kirby Institute" with 6 trials, followed by "University of Sydney" with 6 trials sponsored, "Hoffmann-La Roche" with 5 trials sponsored, "Australian and New Zealand Intensive Care Research Centre" with 4 trials sponsored and "BeiGene" with 4 trials sponsored. Other sponsors include 40 different institutions and companies that sponsored additional 37 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Blacktown Hospital" #1 collaborator was "National Health and Medical Research Council, Australia" with 6 trials as a collaborator, "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 5 trials as a collaborator, "Bristol-Myers Squibb" with 3 trials as a collaborator, "The University of Queensland" with 3 trials as a collaborator and "University of Western Sydney" with 3 trials as a collaborator. Other collaborators include 75 different institutions and companies that were collaborators in the rest 74 trials.

According to Clinical.Site data, the most researched conditions in "Blacktown Hospital" are "Advanced Solid Tumor" (3 trials), "Critical Illness" (3 trials), "Critically Ill" (3 trials), "Advanced Solid Tumours" (2 trials) and "COVID-19" (2 trials). Many other conditions were trialed in "Blacktown Hospital" in a lesser frequency.

Most popular intervention types in "Blacktown Hospital" are "Drug" (49 trials), "Biological" (10 trials), "Other" (10 trials), "Device" (3 trials) and "Diagnostic Test" (3 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (5 trials), "Carboplatin" (4 trials), "Cisplatin" (4 trials), "Cobimetinib" (4 trials) and "Pembrolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "Blacktown Hospital" are 67 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Blacktown Hospital". 2 are not yet recruiting, 36 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Blacktown Hospital, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Blacktown Hospital, 21 "Phase 1" clinical trials were conducted, 22 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 8 trials that are defined as “Not Applicable".